Accord Healthcare, Inc.: Levothyroxine Sodium Tablets, Usp, 125 Mcg (0.125 Mg), 1000-count Bottles
Accord Healthcare is recalling Levothyroxine Sodium Tablets (125 mcg) in 1000-count bottles because the medication contains less active ingredient than it should. The affected product was distributed nationwide across all U.S. states and Washington, D.C. This is a Class II recall, meaning the product could cause adverse health effects.
- Recalling firm
- ACCORD HEALTHCARE, INC.
- Product
- Levothyroxine Sodium Tablets, USP, 125 mcg (0.125 mg), 1000-count bottles, Rx Only, Manufactured for: Accord Healthcare, Inc., Raleigh, NC 27617, Manufactured by: Intas Pharmaceuticals Limited, Camp Road, Selaqui, Dehradun-248 197, India, NDC 16729-453-17.
- Reason
- Subpotent Drug
- Classification
- Class II
- Category
- drug recall
- Country
- United States
- Agency
- U.S. Food and Drug Administration
- Recall date
- 2026-08-06
- Status
- Ongoing
- Areas affected
- AL, AK, AZ, AR, CA, CO, CT, DE, FL, GA, HI, ID, ...
- Distribution
- Nationwide within the United States
Official recall notice from U.S. Food and Drug Administration
Recall details on Nibble Recalls: https://trynibble.app/recalls/55e1f2b7-7641-4a5b-ae2c-e73255d1a4bb